Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease

This study has been completed.
Information provided by (Responsible Party):
Pfizer Identifier:
First received: October 27, 2011
Last updated: August 16, 2016
Last verified: August 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2016
  Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)